Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,091.00 JPY | +1.96% |
|
+7.70% | +93.78% |
Capitalization | 433B 2.92B 2.51B 2.33B 2.17B 4.01B 252B 4.47B 28.2B 10.65B 118B 10.95B 10.73B | P/E ratio 2026 * |
9x | P/E ratio 2027 * | 22.9x |
---|---|---|---|---|---|
Enterprise value | 645B 4.35B 3.73B 3.48B 3.23B 5.97B 374B 6.66B 41.99B 15.85B 176B 16.31B 15.97B | EV / Sales 2026 * |
1.74x | EV / Sales 2027 * | 1.66x |
Free-Float |
42.39% | Yield 2026 * |
-
| Yield 2027 * | 0.34% |
More valuation ratios
* Estimated data
More news
Last Transcript: Sumitomo Pharma Co., Ltd.
More recommendations
More press releases
More news
1 day | +1.96% | ||
1 week | +7.70% | ||
Current month | +12.36% | ||
1 month | +8.99% | ||
3 months | +54.10% | ||
6 months | +98.36% | ||
Current year | +93.78% |
1 week | 988 | ![]() | 1,122 |
1 month | 877 | ![]() | 1,122 |
Current year | 500 | ![]() | 1,122 |
1 year | 401 | ![]() | 1,122 |
3 years | 279 | ![]() | 1,171 |
5 years | 279 | ![]() | 2,363 |
10 years | 279 | ![]() | 4,135 |
Manager | Title | Age | Since |
---|---|---|---|
Toru Kimura
CEO | Chief Executive Officer | 64 | 2024-06-24 |
Kenji Ueno
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isao Shimizu
CTO | Chief Tech/Sci/R&D Officer | - | 2022-03-31 |
Director | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 2025-06-24 | |
Toru Kimura
BRD | Director/Board Member | 64 | 2016-05-31 |
Saeko Arai
BRD | Director/Board Member | 61 | 2018-05-31 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0.38% | 28 M€ | -7.97% | - | |
0.15% | 60,944 M€ | -1.01% | - | |
0.13% | 27,062 M€ | -0.92% | - | |
0.13% | 893 M€ | -0.30% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+1.96% | +7.70% | +157.92% | +2.06% | 2.92B | ||
+1.34% | -2.69% | -10.00% | +136.58% | 693B | ||
+0.44% | +4.33% | +5.82% | -4.65% | 394B | ||
-1.12% | -1.66% | +9.83% | +26.39% | 334B | ||
-2.22% | -5.55% | -53.26% | -1.90% | 287B | ||
+0.58% | +0.66% | -7.15% | -21.43% | 259B | ||
-1.12% | -4.09% | -2.94% | +12.40% | 223B | ||
-0.17% | -1.49% | -15.11% | -7.23% | 215B | ||
-1.91% | -4.08% | -36.42% | -13.43% | 201B | ||
-1.17% | -0.17% | -11.03% | +19.18% | 158B | ||
Average | -0.34% | -0.80% | +3.77% | +14.80% | 276.78B | |
Weighted average by Cap. | -0.22% | -1.65% | -11.20% | +35.07% |
2026 * | 2027 * | |
---|---|---|
Net sales | 371B 2.5B 2.14B 2B 1.86B 3.43B 215B 3.83B 24.11B 9.1B 101B 9.37B 9.17B | 376B 2.53B 2.17B 2.02B 1.88B 3.47B 218B 3.88B 24.45B 9.23B 102B 9.5B 9.3B |
Net income | 48.15B 324M 278M 259M 241M 445M 27.94B 497M 3.13B 1.18B 13.1B 1.22B 1.19B | 18.96B 128M 110M 102M 95.02M 175M 11B 196M 1.23B 466M 5.16B 479M 469M |
Net Debt | 212B 1.43B 1.23B 1.14B 1.06B 1.96B 123B 2.19B 13.79B 5.21B 57.66B 5.36B 5.24B | 189B 1.28B 1.09B 1.02B 949M 1.75B 110B 1.96B 12.32B 4.65B 51.53B 4.79B 4.69B |
More financial data
* Estimated data
Employees
3,832
Sector
Pharmaceuticals
Calendar
Jul. 31
- Q1 2025 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-07-18 | 1,091.00 ¥ | +1.96% | 10,104,700 |
25-07-17 | 1,070.00 ¥ | +4.80% | 7,118,300 |
25-07-16 | 1,021.00 ¥ | +0.49% | 4,731,400 |
25-07-15 | 1,016.00 ¥ | -1.55% | 5,801,100 |
25-07-14 | 1,032.00 ¥ | +1.88% | 5,246,500 |
Delayed Quote Japan Exchange, July 18, 2025 at 02:30 am EDT
More quotesSell
Buy

Mean consensus
HOLD
Number of Analysts
8
Last Close Price
1,091.00JPY
Average target price
797.50JPY
Spread / Average Target
-26.90%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4506 Stock
Select your edition
All financial news and data tailored to specific country editions